Dimensional Fund Advisors’s Viridian Therapeutics VRDN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.79M | Buy |
+485,698
| New | +$6.79M | ﹤0.01% | 2427 |
|
|
2025
Q1 | – | Sell |
-55,924
| Closed | -$1.07M | – | 3358 |
|
|
2024
Q4 | $1.07M | Sell |
55,924
-271,156
| -83% | -$5.2M | ﹤0.01% | 2898 |
|
|
2024
Q3 | $7.44M | Buy |
327,080
+219,500
| +204% | +$4.99M | ﹤0.01% | 2402 |
|
|
2024
Q2 | $1.4M | Buy |
107,580
+97,510
| +968% | +$1.27M | ﹤0.01% | 2849 |
|
|
2024
Q1 | $176K | Hold |
10,070
| – | – | ﹤0.01% | 3201 |
|
|
2023
Q4 | $219K | Hold |
10,070
| – | – | ﹤0.01% | 3181 |
|
|
2023
Q3 | $154K | Hold |
10,070
| – | – | ﹤0.01% | 3254 |
|
|
2023
Q2 | $240K | Sell |
10,070
-856
| -8% | -$20.4K | ﹤0.01% | 3209 |
|
|
2023
Q1 | $278K | Sell |
10,926
-472
| -4% | -$12K | ﹤0.01% | 3140 |
|
|
2022
Q4 | $333 | Hold |
11,398
| – | – | ﹤0.01% | 3116 |
|
|
2022
Q3 | $234K | Hold |
11,398
| – | – | ﹤0.01% | 3208 |
|
|
2022
Q2 | $132K | Buy |
+11,398
| New | +$132K | ﹤0.01% | 3291 |
|
|
2019
Q4 | – | Sell |
-204,562
| Closed | -$150K | – | 3403 |
|
|
2019
Q3 | $150K | Sell |
204,562
-4,404
| -2% | -$3.23K | ﹤0.01% | 3306 |
|
|
2019
Q2 | $428K | Hold |
208,966
| – | – | ﹤0.01% | 3213 |
|
|
2019
Q1 | $583K | Sell |
208,966
-7,900
| -4% | -$22K | ﹤0.01% | 3138 |
|
|
2018
Q4 | $657K | Buy |
216,866
+4,404
| +2% | +$13.3K | ﹤0.01% | 3102 |
|
|
2018
Q3 | $1.19M | Sell |
212,462
-2,300
| -1% | -$12.8K | ﹤0.01% | 3034 |
|
|
2018
Q2 | $1.38M | Buy |
214,762
+50,315
| +31% | +$323K | ﹤0.01% | 2962 |
|
|
2018
Q1 | $1.15M | Buy |
164,447
+99,163
| +152% | +$695K | ﹤0.01% | 2976 |
|
|
2017
Q4 | $681K | Buy |
65,284
+40,061
| +159% | +$418K | ﹤0.01% | 3053 |
|
|
2017
Q3 | $231K | Buy |
+25,223
| New | +$231K | ﹤0.01% | 3205 |
|